S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 EbixNextgen HealthcareOnespanSykes EnterprisesAllscripts Healthcare Solutions
SymbolNASDAQ:EBIXNASDAQ:NXGNNASDAQ:OSPNNASDAQ:SYKENASDAQ:MDRX
Price Information
Current Price$34.14$13.86$18.99$35.20$8.56
52 Week RangeBuyHoldBuyHoldHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyHoldHold
Consensus Price Target$62.97$14.13$20.67$36.50$11.71
% Upside from Price Target84.46% upside1.91% upside8.83% upside3.69% upside36.85% upside
Trade Information
Market Cap$1.08 billion$916.86 million$755.79 million$1.47 billion$1.41 billion
Beta1.561.12.020.861.39
Average Volume224,436206,767173,933137,6581,490,673
Sales & Book Value
Annual Revenue$497.83 million$529.17 million$212.28 million$1.63 billion$1.75 billion
Price / Sales2.091.723.600.900.79
Cashflow$3.85 per share$1.28 per share$0.67 per share$3.68 per share$1.71 per share
Price / Cash8.8710.8028.469.565.00
Book Value$17.41 per share$6.08 per share$6.27 per share$19.32 per share$9.05 per share
Price / Book1.962.283.031.820.95
Profitability
Net Income$93.14 million$24.49 million$3.85 million$48.93 million$412.33 million
EPSN/A$0.61$0.36$2.02$0.55
Trailing P/E Ratio12.5557.7594.9525.327.32
Forward P/E Ratio∞24.3230.6314.9815.85
P/E GrowthN/A$3.08$3.03$1.51$1.57
Net Margins14.64%2.91%3.10%3.62%12.00%
Return on Equity (ROE)22.39%10.58%7.54%10.08%5.98%
Return on Assets (ROA)7.97%7.13%5.31%6.32%2.61%
Dividend
Annual Payout$0.30N/AN/AN/AN/A
Dividend Yield0.88%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.22%0.19%0.04%0.29%0.51%
Current Ratio1.50%1.12%2.77%2.17%0.66%
Quick Ratio1.50%1.12%2.50%2.17%0.66%
Ownership Information
Institutional Ownership Percentage70.73%70.70%68.91%90.73%N/A
Insider Ownership Percentage14.20%18.50%19.30%2.90%1.20%
Miscellaneous
Employees9,2632,660N/A51,6009,500
Shares Outstanding30.50 million65.70 million40.20 million41.43 million162.37 million
Next Earnings Date3/2/2020 (Confirmed)5/26/2020 (Estimated)3/3/2020 (Confirmed)2/26/2020 (Confirmed)3/2/2020 (Confirmed)
OptionableNot OptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel